BOSCHI, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 10.429
AS - Asia 5.644
EU - Europa 4.327
SA - Sud America 1.093
AF - Africa 110
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.637
Nazione #
US - Stati Uniti d'America 10.152
SG - Singapore 2.350
CN - Cina 1.600
IT - Italia 1.172
BR - Brasile 931
PL - Polonia 653
DE - Germania 599
HK - Hong Kong 539
UA - Ucraina 455
GB - Regno Unito 432
VN - Vietnam 358
TR - Turchia 290
FI - Finlandia 252
SE - Svezia 174
RU - Federazione Russa 158
CA - Canada 132
MX - Messico 124
ID - Indonesia 110
IN - India 101
NL - Olanda 78
FR - Francia 72
AR - Argentina 63
ZA - Sudafrica 62
JP - Giappone 59
AT - Austria 50
BE - Belgio 46
ES - Italia 46
BD - Bangladesh 45
AU - Australia 30
CH - Svizzera 28
IQ - Iraq 26
IR - Iran 26
CZ - Repubblica Ceca 24
EC - Ecuador 24
LT - Lituania 21
BG - Bulgaria 18
CO - Colombia 18
UZ - Uzbekistan 18
VE - Venezuela 17
TW - Taiwan 14
CL - Cile 12
HU - Ungheria 12
MA - Marocco 12
MY - Malesia 11
JO - Giordania 10
PK - Pakistan 10
KR - Corea 9
BO - Bolivia 8
IL - Israele 8
KE - Kenya 8
PY - Paraguay 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
EG - Egitto 7
RO - Romania 7
KG - Kirghizistan 5
LB - Libano 5
PT - Portogallo 5
SA - Arabia Saudita 5
UY - Uruguay 5
DK - Danimarca 4
DZ - Algeria 4
GY - Guiana 4
IE - Irlanda 4
LV - Lettonia 4
PH - Filippine 4
TN - Tunisia 4
CR - Costa Rica 3
GA - Gabon 3
HN - Honduras 3
KZ - Kazakistan 3
NP - Nepal 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BB - Barbados 2
BN - Brunei Darussalam 2
CG - Congo 2
CI - Costa d'Avorio 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
KW - Kuwait 2
MK - Macedonia 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BH - Bahrain 1
BY - Bielorussia 1
CD - Congo 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
Totale 21.623
Città #
Singapore 1.344
Ashburn 1.021
Woodbridge 845
Fairfield 782
Warsaw 645
Chandler 572
Beijing 554
Santa Clara 548
Houston 546
Hong Kong 535
Ann Arbor 511
Jacksonville 483
Ferrara 323
Wilmington 303
Seattle 278
Cambridge 225
Los Angeles 220
Nanjing 191
Munich 184
Izmir 179
Dallas 177
New York 170
The Dalles 160
Addison 159
Princeton 144
Milan 124
São Paulo 103
Boardman 101
Ho Chi Minh City 99
Dearborn 82
Dong Ket 81
Shanghai 80
Helsinki 79
Jakarta 77
Mexico City 76
Buffalo 74
Turku 71
Hanoi 65
San Diego 64
London 60
Redwood City 57
Bologna 54
Tokyo 52
Nuremberg 50
Bremen 48
Brooklyn 48
Montreal 47
Nanchang 44
Tianjin 43
Orem 42
Shenyang 41
Brussels 40
Boston 39
Denver 39
Rome 39
Hefei 37
Stockholm 34
Chennai 33
Chicago 32
Phoenix 32
Vienna 32
Toronto 31
Changsha 30
Hebei 30
Johannesburg 30
Moscow 29
Poplar 29
Rio de Janeiro 29
San Francisco 27
Falls Church 24
Legnaro 24
Amsterdam 23
Frankfurt am Main 23
Padova 23
Atlanta 22
Jiaxing 22
Kunming 22
Augusta 21
Chengdu 19
Council Bluffs 19
Guangzhou 19
Ankara 18
Brasília 18
Monmouth Junction 17
Mumbai 17
Ningbo 17
Tashkent 17
Auburn Hills 16
Belo Horizonte 16
Brno 16
Genova 16
Mountain View 16
Norwalk 16
Wuhan 16
Zurich 16
Falkenstein 15
Washington 15
Charlotte 14
Columbus 14
Des Moines 14
Totale 14.018
Nome #
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 466
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 353
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 293
Biodistribution of nanostructured lipid carriers: a tomographic study 279
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 278
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 276
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 254
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 241
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 240
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 239
LARAMED: A Laboratory for Radioisotopes of Medical Interest 239
A solvent-extraction module for cyclotron production of high-purity technetium-99m 225
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 217
YAP-(S)PET small animal scanner: Quantitative results 215
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 212
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 204
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 204
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 203
Radiofarmaci marcati con altri radionuclidi (Indio-111, Rame-64, Iodio-124, Zirconio-89) 192
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 191
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 187
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 185
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 184
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 183
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 179
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 178
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 176
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 175
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 175
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 173
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 170
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 169
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-] 169
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 168
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 168
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 166
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 166
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 166
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 164
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 161
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 160
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 160
Extraction techniques of 99mTc from 100Mo Metal Target 160
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 159
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 158
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 154
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 153
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 152
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 151
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 148
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 147
Produzione e verifiche di qualità dei radiofarmaci prodotti mediante kit 146
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 146
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 146
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 145
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 144
A Comparison of Separation and Purification Strategies for 51/52Mn cyclotron production 142
Development of a β-spectrometer for 99gTc Activity Estimations 142
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 141
Bradykinin B2 receptors increase hippocampal excitability and susceptibility to seizures in mice 139
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 138
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 137
Technetium complexes and radiopharmaceuticals with scorpionate ligands 137
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 136
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 135
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 135
Evaluation of 99Mo and 99mTc Productions Based on a High-Performance Cyclotron 134
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 133
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 131
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 131
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 128
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 125
188W/188Re generator system and its therapeutic applicacions 125
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 124
An alternative method to produce isotopes for medical applications in the framework of the SPES Project: Mo-99 from the UCx target 124
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 121
First Application of the IART Approach with a new Re-188 Labeled Biotin-Derivative 121
Advances in the automation technologies within LARAMED project 119
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 118
Radiopharmacy/Radiochemistry for Conventional Single-Photon Emitting and Therapeutic Radiopharmaceuticals 118
Radioactive metal complexes comprising a tridentate complexing sequence 118
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 117
Production of 47Sc with natural vanadium targets: results of the PASTA project 115
Symmetric bis-substituted and asymmetric mono-substituted nitridotechnetium complexes with heterofunctionalized phosphinothiolate ligands 114
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging 114
Perspectives on the use of liquid extraction for radioisotope purification 112
Recovery of Molybdenum Precursor Material in the Cyclotron-Based Technetium-99m Production Cycle 112
Synthesis and biological evaluation of a novel 99m Tc -Nitrido Labeled Substance P Derivative 111
Efficient preparation and stabilization of Re-188-MDP under physiological conditions 109
null 109
LARAMED: a LAboratoty of RAdioisotopes for MEDicine 109
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 109
Facile preparation of Re-188 radiopharmaceuticals from generator-produced Re-188 perrhenate. 108
Development and Evaluation of the Magnetic Properties of a New Manganese (II) Complex: A Potential MRI Contrast Agent 107
Might Re-188 be more effective for boosting therapy of breast cancer using the IART approach? 107
Cyclotron-Production of 51/52Mn Isotopes: the METRICS Project Final Report 106
Quality control of Tc-99m radiopharmaceuticals: influence of the generator in growth time on the final radiochemical purity 106
Cyclotron-Production of 51/52Mn Isotopes: An Update on the METRICS Project 106
LABELLING OF BIOTIN WITH 188Re 105
A remote-controlled automatic system for the labelling of lipiodol with Re-188 in the treatment of hepatocellular carcinoma 105
Totale 16.245
Categoria #
all - tutte 103.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 10.810
Totale 114.363


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.379 0 0 0 0 0 174 113 290 94 305 244 159
2021/20221.597 71 118 103 75 66 67 83 92 73 125 245 479
2022/20231.419 163 135 42 173 207 189 95 109 130 25 93 58
2023/20241.046 73 94 99 46 69 125 75 73 33 41 51 267
2024/20254.546 120 111 333 182 462 306 196 268 680 555 893 440
2025/20266.119 1.076 436 930 1.467 1.753 457 0 0 0 0 0 0
Totale 22.015